SMT-738: a novel small-molecule inhibitor of bacterial lipoprotein transport targeting Enterobacteriaceae

E B M Breidenstein1, N Khan1, T Duffy1

  • 1Summit Therapeutics, The Works, Unity Campus , Cambridge, United Kingdom.

PubMed

Insights

A new drug, SMT-738, shows potent activity against carbapenem-resistant Enterobacteriaceae (CRE). This novel agent targets essential bacterial mechanisms, offering a promising solution for difficult-to-treat infections.

Area of Science:

  • Microbiology and Infectious Diseases
  • Pharmacology and Drug Development

Background:

  • Carbapenem-resistant Enterobacteriaceae (CRE) pose an urgent global health threat, necessitating novel therapeutic strategies.
  • Existing treatments are limited, driving the need for new antimicrobial agents effective against multidrug-resistant pathogens.

Purpose of the Study:

  • To characterize the microbiological, mechanistic, safety, and pharmacokinetic/pharmacodynamic (PK/PD) profile of SMT-738, a novel small molecule.
  • To evaluate SMT-738's efficacy in preclinical models of Gram-negative bacterial infections.

Main Methods:

  • Microbiological profiling, including minimum inhibitory concentration (MIC) determination against key Enterobacterales.
  • Mechanism of action studies identifying target mutations in the lipoprotein transport complex (LolCDE).
  • In vitro toxicology, pharmacokinetic (PK) studies in animal models, and in vivo efficacy testing in murine infection models (bloodstream, pneumonia, urinary tract).

Main Results:

  • SMT-738 demonstrated potent in vitro activity against multidrug-resistant Escherichia coli and Klebsiella pneumoniae (MIC90 of 1-2 µg/mL).
  • The compound exhibits rapid bactericidal activity, low propensity for resistance development, and targets the essential LolCDE complex.
  • In vivo studies showed significant bacterial burden reduction in bloodstream, pneumonia, and urinary tract infection models, with favorable PK and safety profiles.

Conclusions:

  • SMT-738 is a promising novel drug candidate with a unique mechanism of action against challenging Gram-negative pathogens.
  • Its favorable in vitro and in vivo profiles support further development for treating serious infections caused by carbapenem-resistant Enterobacteriaceae.

Related Concept Videos

Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...